Tali Kizhner
11Patents
2h-index
14Co-inventors
47Inventor score
Filing activity: Mar 2, 2011 → Apr 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9194011B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 6 | Active |
| US9708595B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 3 | Active |
| US10000551B2 | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | Chemistry; Metallurgy | 2 | Active |
| US10280414B2 | Stabilized α-galactosidase and uses thereof | Human Necessities | 2 | Active |
| US10087232B2 | Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US10870842B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 1 | Active |
| US9603906B2 | Inhalable liquid formulations of DNase I | Chemistry; Metallurgy | 0 | Active |
| US9603907B2 | Dry powder formulations of dNase I | Chemistry; Metallurgy | 0 | Active |
| US9732333B2 | Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells | Chemistry; Metallurgy | 0 | Active |
| US12385026B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 0 | Active |
| US10730925B2 | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.